CapsoVision Inc

CapsoVision Inc(CV)資訊與事件

$6.990

+0.195 (+2.79%)收盤時

CV 資訊

CV 事件

9/28 09:30

CapsoVision's AI Highlights Receives FDA Clearance

CapsoVision announced that AI Highlights, its AI-assisted reading tool for the CapsoCam Plus system, received clearance from the U.S. Food and Drug Administration, FDA, on September 25, 2026.

8/27 16:30

Outlook Therapeutics Appoints Kevin Lundquist as CFO

Outlook Therapeutics (OTLK) announced the appointment of Kevin Lundquist as CFO, effective September 1. Lundquist most recently served as CFO of CapsoVision (CV). In connection with Lundquist's appointment, Lawrence Kenyon will step down as CFO effective September 1. Kenyon will continue to support the company as a non-executive employee through September 30.

8/13 17:00

CapsoVision Files $250M Mixed Securities Shelf

CapsoVision files $250M mixed securities shelf

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易